• 건강소식
• /
• v.10 no.7 s.92
• /
• pp.28-30
• /
• 1986

동맥경화증은 중년기나 노년기에만 나타나며 발생하는 것으로 일반에게 알려져 있으나, 실제로 동맥내막에 지방질, 특히 콜레스테롤의 침착은 어릴 때부터 시작되며 중년기나 노년기에는 동맥경화증의 합병증인 심장병이나 뇌졸중이 발생하는 것으로 생각되어 동맥경화증에 대한 예방은 어릴 때부터 시작하여야 한다.

• Bulletin of Food Technology
• /
• v.10 no.3
• /
• pp.4-27
• /
• 1997

동맥경화증과 암은 현대인의 주요한 사망원인들이다. 동맥경화증과 암이 free radical과 관련이 깊다는 보고가 점차 축적되고 있다. 동맥경화증과 암의 발생과 예방, 그리고 지금까지의 연구상황에 대하여 소개하고자 한다.

• 건강소식
• /
• v.35 no.9
• /
• pp.18-20
• /
• 2011

혈관의 안쪽 막인 내막에 콜레스테롤이 침착하고 세포 증식이 일어나면 죽종이라는 것이 만들어진다. 내부는 죽처럼 물러지고 그 주위는 단단한 섬유성 막인 경화반으로 둘러싸이게 되는데, 이를 죽상경화라고 한다. 이렇게 불안정한 경화반이 파열되어 혈관 안에 혈전이 생기고 혈관이 급격하게 좁아지거나 막히는 현상을 죽상동맥경화증이라고 한다. 죽상 동맥경화증은 질병으로 나타나기 전까지는 증상이 없으므로 예방이 중요하다.

• Korean Chemical Engineering Research
• /
• v.62 no.2
• /
• pp.133-141
• /
• 2024

Atherosclerosis, a disease with high morbidity and mortality worldwide, is a chronic inflammatory disease that is a major cause of cardiovascular diseases such as stroke and myocardial infarction. Atherosclerosis is characterized by the accumulation of lipid deposits in the arteries, forming atheromas. This leads to the narrowing of the arteries and thrombosis. Recently, the need to develop bio-derived anti-atherosclerotic materials has been highlighted with concerns about the side effects of synthetic therapeutics. Accordingly, related research (such as the discovery of biomaterials for the improvement and treatment of atherosclerosis and the identification of mechanisms) has been actively conducted. Biomaterials including polysaccharides, polyphenols, and coenzyme Q10 have been reported to inhibit or delay symptoms by modulating factors involved in the development of atherosclerosis. For biomaterials with superior activity, in vivo anti-atherosclerotic activity has been confirmed. In this review, the pathogenesis of atherosclerosis was investigated, and the current status and application prospects of biomaterials with anti-atherosclerotic activity were proposed.

• The Monthly Diabetes
• /
• s.256
• /
• pp.18-21
• /
• 2011

당뇨병환자의 주된 사망 원인은 심장병이다. 당뇨병환자는 동맥경화증이 잘 생기고 이와 관련해 협심증, 심근경색증, 말초혈관질환, 뇌졸중이 잘 생기는 것으로 알려져 있다. 그중에서 관상동맥이 동맥경화증에 의해 막혀 생기는 대표적인 심혈관질환이 바로 협심증과 심근경색이다.

• The Monthly Diabetes
• /
• s.286
• /
• pp.54-57
• /
• 2013

당뇨병 환자에서 동맥 경화증은 가장 흔하고 중요한 합병증 중 하나이며 동맥경화증에 의한 관상동맥질환, 뇌혈관 질환 등 대혈관 질환은 당뇨병이 없는 사람보다 그 빈도가 2-4배 높으며 사망률 또한 높고 뇌졸중 중에서도 특히 뇌경색의 빈도가 높다.

• Journal of Chest Surgery
• /
• v.39 no.4 s.261
• /
• pp.298-303
• /
• 2006

Background: This study was performed to investigate the outcomes of vascular operations that were done in patients with atheroscerosis obliterans (ASO) of lower limb. Material and Method: Forty patients underwent vascular operations from December 1996 to June 2004. The patient's records were analyzed retrospectively. Mean age was $66{\pm}8$ years (range, $47{\sim}81$ years). Gender ratio was 37:3 (male:female). Result: The operations were done on 50 lower limbs of 40 patients. The names of operations were femoropopliteal bypass in 12 patients (30%), femorofemoral bypass in 12 (30%), femorofemoral bypass and femoropopliteal bypass in five (12.5%), aorta-lower limb artery bypass in five (12.5%), axillofemoral bypass in two (5%), iliopopliteal bypass in two (5%), and endarterectomy in two (5%). All bypass surgeries were done with prosthetic conduits. Mean follow up period was $33.2{\pm}23.2$ months (range, $3.8{\sim}90.2$ months). The cumulative patency rates of 1 and 5 years were 75.5 and 58.7% respectively. In six patients, amputation of the lower limb was done. In eight patients, 12 complications occurred. After the first operation, 10 patients underwent reoperations. Conclusion: Our lower limb arterial bypass surgery revealed acceptable patency rate, but not a few patients required reoperations. An epochal treatment modality that can inhibit the progress of ASO and improve long term patency should be established.

• Journal of the Korean Society of Food Science and Nutrition
• /
• v.40 no.4
• /
• pp.531-537
• /
• 2011

The effects of dietary supplementation of pacific saury on anti-hyperlipidemic activities were investigated using an animal test study in which normal rats were fed four different parts of saury, such as the whole body, meat, internal organs, or a mixture of head, caudal fin, and bone. Serum total lipid and triglyceride levels were significantly (p<0.05) reduced in rats fed saury meat at a dose of 200 mg/kg of body weight compared to hyperlipidemic control rats. There were also significant decreases in serum total cholesterol and LDL-cholesterol levels in the rats fed saury meat at 200 mg/kg of body weight. In addition, the atheroscrelosis index and superoxide dismutase in blood lipids were significantly (p<0.05) lowered in rats fed saury meat at 200 mg/kg of body weight compared to the control rats. In conclusion, our results indicate that saury meat contains unknown physiologically active components as than compared to other parts of saury, and has potential for use in the prevention of hyperlipidemic arteriosclerosis.

• Journal of the Korea Society of Computer and Information
• /
• v.25 no.10
• /
• pp.115-123
• /
• 2020

In this paper, we propose to evaluate the potential anti-inflammatory properties of root bark extract of Cudrania (C.) tricuspidata on lipopolysaccharide (LPS)-induced inflammation in macrophages of apolipoprotein E (ApoE) knockout (ApoE^-/-) mice, murine model of atherosclerosis. Atherosclerosis is a chronic vascular inflammatory disease. C. tricuspidata is a small tree of the Moraceae family and its extract has anti-inflammatory activities. However, its role in the progress of atherosclerosis is not yet clear. To determine anti-inflammatory effects of C. tricuspidata in atherogenesis, we applied LPS in peritoneal macrophages of ApoE^-/- mice and measured cell viability by CCK-8 and expression of pro-inflammatory cytokines by qRT-PCR following treatment with root bark extract of C. tricuspidata. Research data was expressed as differences between the cells treated with LPS and root bark extract and the cells treated with LPS alone (control) by a two-tailed non-parametric Mann-Whitney U-test using GraphPad Instat program. No cytotoxic effect was observed when the cells were treated with the extract at concentrations ≤ 100 ㎍/mL. The expression of inflammatory cytokines, including MCP-1, IL-1β, IFN-γ, TNF-α, and IL-6 were inhibited by the extract. These results indicated that the extract has an anti-inflammatory effect and therefore a possible role in the treatment of atherosclerosis.

• Journal of Chest Surgery
• /
• v.39 no.8 s.265
• /
• pp.619-625
• /
• 2006

Background: Peripheral arterial disease is frequently accompanied with systemic arteriosclerosis and more than half of the cause of deaths is due to the development of coronary arterial disease. Moreover, it is known that the most frequent cause of death after a bypass surgery of chronic arterial obstruction is heart related complications. Especially in patients with atherosclerotic arterial obstruction in the lower extremities who had no history of heart disease or had no presenting symptoms of ischemic heart disease showed a high rate of postoperative mortality and for this reason we suggest preoperative evaluation in these patients to evaluate whether or not coronary arterial disease is accompanied. Material and Method: Since Feb. 2001 to Oct. 2004, we analyzed 52 patients who were operated on for atherosclerotic arterial obstruction in the lower extremities, with the exception of patients with a past history of heart disease or symptoms of ischemic heart disease. They underwent on the same day a coronary and femoral angiography for evaluation of accompanying coronary arterial disease. Of among these patients, we compared those who received bypass surgery of the arteries of the peripheral extremities alone to those who underwent combined coronary artery bypass surgery. Result: 63% of the reported cases of atherosclerotic arterial obstruction in the lower extremities were accompanied with coronary arterial disease. Old age, hypertension, diabetes mellitus, smoking, and hypercholesterolemia are known risk factors for arteriosclerosis and of these, only old age and hypertension had statistically significance in patients with severe atherosclerotic arterial obstruction in the lower extremities accompanied with coronary arterial disease. Diabetes, smoking, and hypercholesterolemia showed no statistical significance in this group. With the increase in severity of the range and the degree of atherosclerotic arterial obstruction, coronary arterial disease is frequently accompanied and its severity also increased. Patients who received both peripheral artery and coronary artery bypass surgery showed no difference in the period of hospitalization and ICU stay period compared with patients who received bypass surgery of the arteries of the lower extremities alone. Conclusion: Patients with atherosclerotic arterial obstruction in the lower extremities without symptoms of ischem to evaluate coronary arterial disease for active treatment, especially in the patients with old age, hypertension and high AVD scores.